Size of the Tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy? (original) (raw)

Abstract

Background

Size can predict malignancy in adrenocortical tumors, but the same extrapolation for pheochromocytomas (PCC) is controversial. The goal of this study was to find a correlation between the tumor size and malignant potential of PCC and determine whether the “Pheochromocytoma of the adrenal gland scaled score” (PASS) proposed by Thompson can be applied to predict malignancy.

Methods

A retrospective analysis of patients with PCC operated on from 1991 to 2007 revealed 98 PCC removed from 93 patients. Tumor size was available for 90 tumors. Six (6.4%) patients had proven malignancy. Five familial cases were excluded from the PASS analysis.

Results

Of the benign cases, none developed recurrence or metastasis. There were 54 (60%) tumors > 6 cm and 36 (40%) tumors ≤ 6 cm. All 12 PASS parameters were individually present in higher frequency in the >6-cm group; but the difference was not statistically significant except cellular monotony (p = 0.02). Overall, a PASS ≤ 4 was found in 57 patients. Mean PASS was statistically significantly higher in the >6-cm group (4.4 vs. 3.3, p = 0.04). Of the sporadic benign cases, 21 (41%) patients with tumor size > 6 cm had a PASS of >4, and none of them developed metastasis. PASS ≤ 4 was found in 25 (81%) PCC in the ≤6-cm group, and none developed metastases. PASS ≥ 4 was found in six (19%) patients in the ≤6-cm group, and none developed metastases. 68 patients completed 5-year follow-up, and the remaining had a mean follow-up of 28.7 months. No correlation was found between tumor size and PASS > 4 and PASS ≤ 4 (7.8 cm vs. 7.1 cm; p = 0.23).

Conclusions

Presently there is not enough evidence to indict a large (>6 cm) PCC as malignant. Furthermore, PASS cannot be reliably applied to PCC for predicting malignancy.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kim HH, Kim GH, Sung GT (2004) Laparoscopic adrenalectomy for pheochromocytoma: comparison with conventional open adrenalectomy. J Endourol 18(3):251–255
    Article CAS PubMed Google Scholar
  2. Davies MJ, McGlade DP, Banting SW (2004) A comparison of open and laparoscopic approaches to adrenalectomy in patients with phaeochromocytoma. Anaesth Intensive Care 32(2):224–229
    CAS PubMed Google Scholar
  3. Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE, Gauger PG (2003) Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134(6):918–922 discussion 922–923
    Article PubMed Google Scholar
  4. Thompson LD (2002) Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26(5):551–566
    Article PubMed Google Scholar
  5. Wu D, Tischler AS, Lloyd RV, DeLellis RA, de Krijger R, van Nederveen F et al (2009) Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 33(4):599–608
    Article PubMed Google Scholar
  6. Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143(6):759–768
    Article PubMed Google Scholar
  7. Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134(2):181–185
    Article CAS PubMed Google Scholar
  8. Goldstein RE, O’Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW III, Oates JA et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229(6):755–764 discussion 764-766
    Article CAS PubMed Google Scholar
  9. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison EG Jr (1974) Current management of pheochromocytoma. Ann Surg 179(5):740–748
    Article CAS PubMed Google Scholar
  10. van Heerden JA, Roland CF, Carney JA, Sheps SG, Grant CS (1990) Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg 14(3):325–329
    Article PubMed Google Scholar
  11. Proye C, Vix M, Goropoulos A, Kerlo P, Lecomte-Houcke M (1992) High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 15(9):651–663
    CAS PubMed Google Scholar
  12. Proye CA, Vix M, Jansson S, Tisell LE, Dralle H, Hiller W (1994) “The” pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J Surg 18(4):467–472
  13. O'Riordain DS, Young WF Jr, Grant CS, Carney JA, van Heerden JA (1996) Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg 20(7):916–921
    Article PubMed Google Scholar
  14. Linnoila RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21(11):1168–1180
    Article CAS PubMed Google Scholar
  15. Nativ O, Grant CS, Sheps SG, O’Fallon JR, Farrow GM, van Heerden JA et al (1992) Prognostic profile for patients with pheochromocytoma derived from clinical and pathological factors and DNA ploidy pattern. J Surg Oncol 50(4):258–262
    Article CAS PubMed Google Scholar
  16. John H, Ziegler WH, Hauri D, Jaeger P (1999) Pheochromocytomas: can malignant potential be predicted? Urology 53(4):679–683
    Article CAS PubMed Google Scholar
  17. Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK (2005) Normotensive pheochromocytoma: institutional experience. World J Surg 29(9):1185–1188
    Article PubMed Google Scholar

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Endocrine Surgery, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Rai Bareilly Road, Lucknow, 226014, India
    Amit Agarwal, Prateek K. Mehrotra, Anjali Mishra, Gyan Chand, Gaurav Agarwal, A. K. Verma & S. K. Mishra
  2. Department of Pathology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India
    Manoj Jain
  3. Department of Endocrinology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India
    Sushil K. Gupta
  4. Department of Biostatistics, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India
    Uttam Singh

Authors

  1. Amit Agarwal
    You can also search for this author inPubMed Google Scholar
  2. Prateek K. Mehrotra
    You can also search for this author inPubMed Google Scholar
  3. Manoj Jain
    You can also search for this author inPubMed Google Scholar
  4. Sushil K. Gupta
    You can also search for this author inPubMed Google Scholar
  5. Anjali Mishra
    You can also search for this author inPubMed Google Scholar
  6. Gyan Chand
    You can also search for this author inPubMed Google Scholar
  7. Gaurav Agarwal
    You can also search for this author inPubMed Google Scholar
  8. A. K. Verma
    You can also search for this author inPubMed Google Scholar
  9. S. K. Mishra
    You can also search for this author inPubMed Google Scholar
  10. Uttam Singh
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toAmit Agarwal.

Additional information

Amit Agarwal and Prateek K. Mehrotra are joint first authors.

Rights and permissions

About this article

Cite this article

Agarwal, A., Mehrotra, P.K., Jain, M. et al. Size of the Tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy?.World J Surg 34, 3022–3028 (2010). https://doi.org/10.1007/s00268-010-0744-5

Download citation

Keywords